Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 43

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 43
---
----|:----------------|:--|:----|:------|--------:|
| Michael Giuffre, M.D. |     | $               | 56,190 |     | $            | 59,210 |     | $            | 575 |     |                 | — |     | $     | 115,975 |
| Richard Kuntz, M.D.   |     |                 | 45,516 |     |              | 59,210 |     |              | 427 |     |                 | — |     |       | 105,153 |
| Tanya Lewis           |     |                 | 47,758 |     |              | 59,210 |     |              |   — |     |                 | — |     |       | 106,968 |
| James Parsons         |     |                 | 60,000 |     |              | 59,210 |     |              | 641 |     |                 | — |     |       | 119,851 |
| Richard Pilnik        |     |                 | 85,500 |     |              | 75,001 |     |              | 910 |     |                 | — |     |       | 161,411 |
| Charles Semba, M.D.   |     |                 | 55,258 |     |              | 59,210 |     |              | 281 |     |                 | — |     |       | 114,749 |

| (1) | The following directors elected to receive DSUs or RSUs in exchange for all or part of their cash retainers: Dr. Giuffre ($53,750 was paid in the form of 19,196 DSUs); Dr. Kuntz ($40,000 was paid in the form of 14,285 RSUs); Mr. Parsons ($60,000 was paid in the form of 21,428 DSUs); Mr. Pilnik ($85,000 was paid in the form of 30,357 DSUs); and Dr. Semba ($26,250 was paid in the form of 9,375 RSUs). |

| (2) | Amounts reflect the grant date fair value for option awards granted to each non-employee director computed in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. |

| (3) | The following current directors held the following option awards as of December 31